Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L (2001). Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Multiple Sclerosis 7, 340–344.
Anderson JS, Ferrans CE (1997). The quality of life of persons with chronic fatigue syndrome. Journal of Nervous and Mental Disease 185, 359–367.
Andrykowski MA, Curran SL, Lightner R (1998). Off-treatment fatigue in breast cancer survivors: a controlled comparison. Journal of Behavioral Medicine 21, 1–18.
Black PH (2002). Stress and the inflammatory response: a review of neurogenic inflammation. Brain, Behavior, and Immunity 16, 622–653.
Buchwald D, Wener MH, Pearlman T, Kith P (1997). Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. Journal of Rheumatology 24, 372–376.
Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L, Wolff SM, Komaroff AL (1997). Interleukin-1β, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. Journal of Clinical Immunology 17, 253–261.
Cannon JG, Angel JB, Ball RW, Abad LW, Fagioli L, Komaroff AL (1999). Acute phase responses and cytokine secretion in chronic fatigue syndrome. Journal of Clinical Immunology 19, 414–421.
Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH (2002). Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643–652.
Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, Miller AH (2005). Anterior cingulate activation and error processing during interferon-alpha treatment. Biological Psychiatry 58, 190–196.
Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B, Berns GS, Nemeroff CB, Miller AH (2007). Basal ganglia hypermetabolism and symptoms of fatigue during interferon-α therapy. Neuropsychopharmacology 32, 2384–2392.
Chao CC, Janoff EN, Hu SX, Thomas K, Gallagher M, Tsang M, Peterson PK (1991). Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 3, 292–298.
Cho HJ, Menezes PR, Hotopf M, Bhugra D, Wessely S (2009 a). Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition. British Journal of Psychiatry 194, 117–122.
Cho HJ, Seeman TE, Bower JE, Kiefe CI, Irwin MR (2009 b). Prospective association between C-reactive protein and fatigue in the Coronary Artery Risk Development in Young Adults study. Biological Psychiatry 66, 871–878.
Cole SW, Arevalo JM, Manu K, Telzer EH, Kiang L, Bower JE, Irwin MR, Fuligni AJ (2011). Antagonistic pleiotropy at the human IL6 promoter confers genetic resilience to the pro-inflammatory effects of adverse social conditions in adolescence. Developmental Psychology 47, 1173–1180.
Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR (2006). Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research 12, 2759–2766.
Compston A, Coles A (2002). Multiple sclerosis. Lancet 359, 1221–1231.
Corwin EJ, Klein LC, Rickelman K (2002). Predictors of fatigue in healthy young adults: moderating effects of cigarette smoking and gender. Biological Research for Nursing 3, 223.
Curt G (2000). Impact of fatigue on quality of life in oncology patients. Seminars in Hematology 37, 14–17.
Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM (2005). Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Care and Research 53, 5–11.
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000). Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 321, 199–204.
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46–56.
Dimsdale JE, Dantzer R (2007). A biological substrate for somatoform disorders: importance of pathophysiology. Psychosomatic Medicine 69, 850–854.
Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR (2010). Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain, Behavior, and Immunity 24, 558–563.
Fava M (2006). Pharmacological approaches to the treatment of residual symptoms. Journal of Psychopharmacology 20, 29–34.
Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P (2004). Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Multiple Sclerosis 10, 165–169.
Gimeno D, Delclos GL, Ferrie JE, De Vogli R, Elovainio M, Marmot MG, Kivimäki M (2011). Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. European Journal of Epidemiology 26, 135–144.
Giovannoni G, Thompson AJ, Miller DH, Thompson EJ (2001). Fatigue is not associated with raised inflammatory markers in multiple sclerosis. Neurology 57, 676–681.
Goldberg DP (1972). The Detection of Psychiatric Illness by Questionnaire. Oxford University Press: London.
Gupta S, Aggarwal S, See D, Starr A (1997). Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. Journal of Psychiatric Research 31, 149–156.
Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM (2006). Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? Journal of Neurology, Neurosurgery and Psychiatry 77, 34–39.
Kashipaz MRA, Swinden D, Todd I, Powell RJ (2003). Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clinical and Experimental Immunology 132, 360–365.
Klimas NG, Broderick G, Fletcher MA (2012). Biomarkers for chronic fatigue. Brain, Behavior, and Immunity. Published online 23 06 2012. doi:10.1016/j.bbi.2012.06.006.
Kumari M, Head J, Marmot M (2004). Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Archives of Internal Medicine 164, 1873–1880.
LaManca JJ, Sisto SA, Zhou X, Ottenweller JE, Cook S, Peckerman A, Zhang Q, Denny TN, Gause WC, Natelson BH (1999). Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. Journal of Clinical Immunology 19, 135–142.
Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825–830.
Marmot M, Brunner E (2005). Cohort profile: the Whitehall II study. International Journal of Epidemiology 34, 251–256.
Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology 26, 971–982.
Moss RB, Mercandetti A, Vojdani A (1999). TNF-α and chronic fatigue syndrome. Journal of Clinical Immunology 19, 314–316.
O'Connor PJ (2004). Evaluation of four highly cited energy and fatigue mood measures. Journal of Psychosomatic Research 57, 435–441.
Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC (1994). Population based study of fatigue and psychological distress. British Medical Journal 308, 763–766.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr., Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association (2003). Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511.
Pepys MB, Hirschfield GM (2003). C-reactive protein: a critical update. Journal of Clinical Investigation 111, 1805–1812.
Ricci JA, Chee E, Lorandeau AL, Berger J (2007). Fatigue in the U.S. workforce: prevalence and implications for lost productive work time. Journal of Occupational and Environmental Medicine 49, 1–10.
Ritsner M, Ponizovsky A, Endicott J, Nechamkin Y, Rauchverger B, Silver H, Modai I (2002). The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. European Neuropsychopharmacology 12, 31–38.
Saligan LN, Kim HS (2012). A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain, Behavior, and Immunity 26, 830–848.
Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE (2007). The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain, Behavior, and Immunity 21, 413–427.
Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J (1998). Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. Journal of Clinical Endocrinology and Metabolism 83, 1573–1579.
Stansfeld S, Marmot M (1992). Social class and minor psychiatric disorder in British civil servants: a validated screening survey using the General Health Questionnaire. Psychological Medicine 22, 739–749.
Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D (2003 a). Cost of lost productive work time among US workers with depression. Journal of the American Medical Association 289, 3135–3144.
Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R (2003 b). Lost productive time and cost due to common pain conditions in the US workforce. Journal of the American Medical Association 290, 2443–2454.
Steyerberg EW, Eijkemans MJ, Harrell FE Jr., Habbema JD (2000). Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Statistics in Medicine 19, 1059–1079.
ter Wolbeek M, van Doornen LJP, Kavelaars A, van de Putte EM, Schedlowski M, Heijnen CJ (2007). Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain, Behavior, and Immunity 21, 1063–1074.
Valdini AF (1985). Fatigue of unknown aetiology – a review. Family Practice 2, 48–53.
Vollmer-Conna U, Cameron B, Hadzi-Pavlovic D, Singletary K, Davenport T, Vernon S, Reeves W, Hickie I, Wakefield D, Lloyd A (2007). Postinfective fatigue syndrome is not associated with altered cytokine production. Clinical Infectious Diseases 45, 732–735.
Ware J Jr., Kosinski M, Keller SD (1996). A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34, 220–233.
Ware JE (1993). SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center: Boston.
Wener MH, Daum PR, McQuillan GM (2000). The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. Journal of Rheumatology 27, 2351–2359.
White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, Bavinton J, Angus BJ, Murphy G, Murphy M, O'Dowd H, Wilks D, McCrone P, Chalder T, Sharpe M (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377, 823–836.
Wolfe F (2004). Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. Journal of Rheumatology 31, 1896–1902.
Zajecka JM (2000). Clinical issues in long-term treatment with antidepressants. Journal of Clinical Psychiatry 61, 20–25.
Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ, Lavietes MH, Pollet C, Gause WC, Natelson BH (1999). Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clinical and Diagnostic Laboratory Immunology 6, 6–13.